KORU Medical Systems Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
KRMD Nasdaq 3841 https://www.korumedical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for KORU Medical Systems Inc

Here's Why We're Not At All Concerned With KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Situation - Sep 6th, 2024 1:46 pm
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference - Sep 5th, 2024 11:00 am
Analysts Are Updating Their KORU Medical Systems, Inc. (NASDAQ:KRMD) Estimates After Its Second-Quarter Results - Aug 10th, 2024 1:00 pm
KORU Medical Systems Second Quarter 2024 Earnings: Beats Expectations - Aug 9th, 2024 11:32 am
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance - Aug 7th, 2024 8:05 pm
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference - Jul 25th, 2024 8:05 pm
KORU Medical Systems, Inc. (NASDAQ:KRMD) is definitely on the radar of institutional investors who own 33% of the company - Jul 25th, 2024 12:46 pm
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda - Jul 24th, 2024 8:05 pm
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 - Jul 17th, 2024 8:05 pm
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan - Jul 2nd, 2024 11:00 am
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion - Jun 5th, 2024 1:00 pm
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic - Jun 4th, 2024 8:03 pm
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic - May 14th, 2024 8:05 pm
It Looks Like KORU Medical Systems, Inc.'s (NASDAQ:KRMD) CEO May Expect Their Salary To Be Put Under The Microscope - May 3rd, 2024 11:55 am
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ... - May 2nd, 2024 7:39 am
KORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Challenges - May 1st, 2024 10:06 pm
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth - May 1st, 2024 8:05 pm
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 - Apr 17th, 2024 11:00 am
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review - Apr 11th, 2024 8:05 pm
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference - Mar 18th, 2024 9:24 pm